Last reviewed · How we verify
NCT05919173
Comparison Between Bupivacaine and Bupivacaine With Dexmedetomidine in Caudal Block for Post Operative Pain Control
Phase 4 trial testing Bupivacaine Hydrochloride 0.25% Injection Solution in Post Operative Pain in 60 participants. Completed in 20 November 2021.
15 November 2021
Quick facts
| Lead sponsor | Sindh Institute of Urology and Transplantation |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 60 |
| Start date | 10 July 2021 |
| Primary completion | 15 November 2021 |
| Estimated completion | 20 November 2021 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Bupivacaine Hydrochloride 0.25% Injection Solution
- Bupivacaine Hydrochloride 0.25% Injection plus Dexmedetomidine 1 microgram/kg body weight — full drug profile →
Conditions studied
- Post Operative Pain — all drugs for Post Operative Pain →
Sponsor
Sindh Institute of Urology and Transplantation
Who can join
Adults 2 Months to 7, any sex, with Post Operative Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to compare the duration of analgesia, sedation, and intra and postoperative hemodynamics. This drug is recently available in Pakistan. To the best of our knowledge, no published data is available in this respect in Pakistan, so this study would in turn help to fill the gap in knowledge in low-resource settings/emerging economy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05919173
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Bupivacaine Hydrochloride 0.25% Injection Solution
Trials testing the same drug.
- NCT03283436 — RCT Superior Hypogastric Block During LH · Phase 4 · completed
Other recruiting trials for Post Operative Pain
Currently open trials in the same condition.
- NCT06779604 — Dexmedetomidine and Dexamethasone Added as Adjuvant Infraclavicular Brachial Plexus Block in Upper Limb Surgery · recruiting
- NCT07223580 — A Study Of Corticosteroid On Postoperative Pain After Ureteroscopy For Urinary Calculi · Phase 4 · recruiting
- NCT07227064 — Methadone in THA for Post-op Pain and Opioid Reduction · Phase 3 · recruiting
- NCT07226076 — Methadone in TKA for Post-op Pain and Opioid Reduction · Phase 3 · recruiting
- NCT07349810 — Post Operative Infusion Pump Pain Study · Phase 4 · recruiting
Other Sindh Institute of Urology and Transplantation trials
Trials by the same sponsor.
- NCT07510178 — Retrograde Intrarenal Surgery Versus Extracorporeal Shockwave Lithotripsy · NA · not yet recruiting
- NCT07512141 — Single Versus Double Drains in the Axillary and Pectoral Regions After Modified Radical Mastectomy · NA · recruiting
- NCT07493356 — Difficult Airway Prediction by Integrating STOP-BANG Criteria · recruiting
- NCT07510542 — Comparison of Stress Response Evoked by Conventional Versus Videolaryngoscope · NA · recruiting
- NCT07334548 — Post-Surgical Outcomes of Conventional vs 3-Point Mesh Fixation in Lichtenstein Repair: An RCT · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05919173 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sindh Institute of Urology and Transplantation
- Last refreshed: 11 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05919173.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing